372 related articles for article (PubMed ID: 28692169)
21. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
22. HEREDITARY ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY IN PEDIATRIC PATIENTS IN CROATIA - FIRST NATIONAL STUDY, DIAGNOSTIC AND PROPHYLACTIC CHALLENGES.
Karadža-Lapić L; Barešić M; Vrsalović R; Ivković-Jureković I; Sršen S; Prkačin I; Rijavec M; Cikojević D
Acta Clin Croat; 2019 Mar; 58(1):139-146. PubMed ID: 31363336
[TBL] [Abstract][Full Text] [Related]
23. Psychology and hereditary angioedema: A systematic review.
Savarese L; Mormile I; Bova M; Petraroli A; Maiello A; Spadaro G; Freda MF
Allergy Asthma Proc; 2021 Jan; 42(1):e1-e7. PubMed ID: 33404395
[No Abstract] [Full Text] [Related]
24. Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.
Ocak M; Nain E; Akarsu A; Sahiner UM; Sekerel BE; Soyer O
Allergy Asthma Proc; 2021 Jul; 42(4):325-332. PubMed ID: 34187624
[No Abstract] [Full Text] [Related]
25. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.
Andrási N; Veszeli N; Kőhalmi KV; Csuka D; Temesszentandrási G; Varga L; Farkas H
J Allergy Clin Immunol Pract; 2018; 6(4):1205-1208. PubMed ID: 29715562
[TBL] [Abstract][Full Text] [Related]
26. Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Palao-Ocharan P; Prior N; Pérez-Fernández E; Caminoa M; ; Caballero T
Orphanet J Rare Dis; 2022 Mar; 17(1):88. PubMed ID: 35236380
[TBL] [Abstract][Full Text] [Related]
27. HAE-AS: A Specific Disease Activity Scale for Hereditary Angioedema With C1-Inhibitor Deficiency.
Forjaz MJ; Ayala A; Caminoa M; Prior N; Pérez-Fernández E; Caballero T;
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):246-252. PubMed ID: 31932270
[TBL] [Abstract][Full Text] [Related]
28. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
Lyseng-Williamson KA
BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
[TBL] [Abstract][Full Text] [Related]
29. Parameters of the classical complement pathway predict disease severity in hereditary angioedema.
Csuka D; Füst G; Farkas H; Varga L
Clin Immunol; 2011 Apr; 139(1):85-93. PubMed ID: 21300570
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J
Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584
[TBL] [Abstract][Full Text] [Related]
31. Hereditary angioedema: Epidemiology and burden of disease.
Lumry WR; Settipane RA
Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S08-S13. PubMed ID: 33109318
[TBL] [Abstract][Full Text] [Related]
32. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life and its risk factors in Chinese hereditary angioedema patients.
Liu S; Wang X; Xu Y; Xu Q; Zhi Y
Orphanet J Rare Dis; 2019 Aug; 14(1):191. PubMed ID: 31395105
[TBL] [Abstract][Full Text] [Related]
34. [Guidelines for the diagnosis and treatment of hereditary angioedema].
Marković AS; Rozmanić V; Anić B; Aberle N; Racić G; Novak S; Sunara D; Grdinić B; Karadza-Lapić L; Radas MR; Karanović B; Kvenić B
Lijec Vjesn; 2014; 136(5-6):117-29. PubMed ID: 25154179
[TBL] [Abstract][Full Text] [Related]
35. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
Bork K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
[TBL] [Abstract][Full Text] [Related]
36. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
[TBL] [Abstract][Full Text] [Related]
37. Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry.
Psarros F; Koutsostathis N; Farmaki E; Speletas MG; Germenis AE
Int Arch Allergy Immunol; 2014; 164(4):326-32. PubMed ID: 25277223
[TBL] [Abstract][Full Text] [Related]
38. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
39. Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency.
Márkus B; Veszeli N; Temesszentandrási G; Farkas H; Kalabay L
Orphanet J Rare Dis; 2019 Mar; 14(1):67. PubMed ID: 30885236
[TBL] [Abstract][Full Text] [Related]
40. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
